Cascadia Investments, Inc. Announces Acquisition of a Boutique Advertising Network
August 18 2009 - 9:15AM
Marketwired
Cascadia Investments, Inc. (PINKSHEETS: CDIV) announces the
acquisition of www.pharmads.com, a boutique advertising network
specifically designed for use by advertisers and publishers of
pharmaceutical-related brands, sites, and products. In the last
seven years, with changes in FDA guidelines, expenditures on
direct-to-consumer pharmaceutical advertising have quintupled.
Currently, more than $30 billion is spent annually marketing
pharmaceuticals, a figure that is expected to grow as drug
companies search for new advertising outlets.
Pharmads.com is the first in a series of boutique ad networks
that Cascadia plans to launch in the coming months, each
specializing in a specific niche market. In addition, the company
plans to develop additional supplemental sites that will further
diversify each niche market.
Please check out Cascadia's new website at
www.cascadiainteractive.com for the latest details on all of our
Internet properties.
About Cascadia Investments, Inc.
Cascadia Investments, Inc. (PINKSHEETS: CDIV) is a publicly
traded, real estate development company operating in the Pacific
Northwest. The company's principal objective is to create equity
and long-term earnings growth through the acquisition and
development of undervalued real estate and cutting edge internet
properties.
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995: Except for historical information, the forward
looking matters discussed in this news release are subject to
certain risks and uncertainties which could cause the Company's
actual results and financial condition to differ materially from
those anticipated by the forward-looking statements including, but
not limited to, the Company's liquidity and the ability to obtain
financing, the timing of regulatory approvals, uncertainties
related to corporate partners or third parties, product liability,
the dependence on third parties for manufacturing and marketing,
patent risk, copyright risk, competition, and the early stage of
products being marketed or under development, as well as other
risks indicated from time to time in the Company's filings with the
Securities and Exchange Commission. The Company assumes no
obligation to update or supplement forward-looking statements that
become untrue because of subsequent events.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact: Cascadia Investments, Inc. Tel: 253-383-7194
Cascadia Investments (PK) (USOTC:CDIV)
Historical Stock Chart
From Nov 2024 to Dec 2024
Cascadia Investments (PK) (USOTC:CDIV)
Historical Stock Chart
From Dec 2023 to Dec 2024